Industry Canada has indicated that changes will be made to the Patented Medicine (Notice of Compliance) Regulations relating to the listing of patents on the Patent Register claiming single medicinal ingredients found in combination drugs.
Monthly Archives: November 2014
On Friday, the United States Court of Appeals for the Federal Circuit held in Ultramercial, Inc. v. Hulu LLC that the claims to a method of distributing copyrighted media over the Internet were directed to unpatentable subject matter . The U.S. Supreme Court had previously remanded the proceeding back to the CAFC after Myriad and again after Alice when, in both previous cases, the court had found the claims patentable. Continue reading Third Round
As indicated below, Children’s Hospital of Eastern Ontario (CHEO) has started litigation against the University of Utah Research Foundation, Genzyme Genetics and Yale University. The litigation seeks a declaration of non-infringement and invalidity of certain patents relating to Long QT Syndrome genes, including on the basis of non-patentable subject matter. Continue reading Gene Patents
Tomorrow, the Supreme Court of Canada was scheduled to hear arguments in Apotex Inc., et al. v. Sanofi-Aventis, et al. (Plavix/clopidogrel), including on the issue of patent utility/promise but this afternoon the Court announced that the hearing will NOT go ahead. Apotex has discontinued its appeal. Continue reading SCC